Seratrodast
Product Specifications
CAS Number
112665-43-7
Target
Reactive Oxygen Species|||Ferroptosis|||JNK|||MDM-2/p53|||COX|||Prostaglandin Receptor|||ROS|||PPAR
Related Pathways
GPCR/G Protein|||NF-?B|||Neuroscience|||MAPK|||Metabolism|||DNA Damage/DNA Repair|||Immunology/Inflammation|||Apoptosis
Purity
0.9969
Bioactivity
Seratrodast (ABT-001) (INN), a thromboxane A2 (TXA2) receptor (TP receptor) antagonist, is mainly used in the therapy of asthma. It was the first TP receptor antagonist developed as an anti-asthmatic drug and attained marketing qualification in Japan in 1997.
Smiles
C(CCCCCC(O)=O)(C1=C(C)C(=O)C(C)=C(C)C1=O)C2=CC=CC=C2
Molecular Formula
C22H26O4
Molecular Weight
354.44
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1131107-01 0.02 mg (E-Coli)
Recombinant Vaccinia virus Uncharacterized 9.9 kDa protein (F ORF D)
Ask
View Details 
MBS1131107-02 0.1 mg (E-Coli)
Recombinant Vaccinia virus Uncharacterized 9.9 kDa protein (F ORF D)
Ask
View Details MBS1131107-03 0.02 mg (Yeast)
Recombinant Vaccinia virus Uncharacterized 9.9 kDa protein (F ORF D)
Ask
View Details 
MBS1131107-04 0.1 mg (Yeast)
Recombinant Vaccinia virus Uncharacterized 9.9 kDa protein (F ORF D)
Ask
View Details MBS1131107-05 0.02 mg (Baculovirus)
Recombinant Vaccinia virus Uncharacterized 9.9 kDa protein (F ORF D)
Ask
View Details MBS1131107-06 1 mg (E-Coli)
Recombinant Vaccinia virus Uncharacterized 9.9 kDa protein (F ORF D)
Ask
View Details